Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Olivia Khouri"'
Autor:
Benson Chellakkan Selvanesan, Dinesh Chandra, Wilber Quispe-Tintaya, Arthee Jahangir, Ankur Patel, Kiran Meena, Rodrigo Alberto Alves Da Silva, Madeline Friedman, Lisa Gabor, Olivia Khouri, Steven K. Libutti, Ziqiang Yuan, Jenny Li, Sarah Siddiqui, Amanda Beck, Lydia Tesfa, Wade Koba, Jennifer Chuy, John C. McAuliffe, Rojin Jafari, David Entenberg, Yarong Wang, John Condeelis, Vera DesMarais, Vinod Balachandran, Xusheng Zhang, Ken Lin, Claudia Gravekamp
Publikováno v:
Sci Transl Med
Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease. Tumors are poorly immunogenic and immunosuppressive, preventing T cell activation in the tumor microenvironment. Here, we present a microbial-based immunotherapeutic treatment fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7165cab37dfef362f8df9e55a2205f54
https://doi.org/10.1126/scitranslmed.abc1600
https://doi.org/10.1126/scitranslmed.abc1600
Autor:
David Smotkin, Olivia Khouri, Alexander Fife, Nicole S. Nevadunsky, Sara Isani, Arielle Katcher, Melissa Fazzari, Dennis Yi-Shin Kuo
Publikováno v:
Gynecologic Oncology. 162:S209-S210
Objectives: The treatment of advanced epithelial ovarian cancer (EOC) involves a combination of cytoreductive surgery and chemotherapy. For patients with unresectable disease or extensive comorbidities at the time of diagnosis, administration of neoa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a594c5c662ca86bb9516f1ae7891a1
https://doi.org/10.1016/s0090-8258(21)01050-7
https://doi.org/10.1016/s0090-8258(21)01050-7
Autor:
Olivia Khouri, Gregory M. Gressel, Divya Gowthaman, Anne Van Arsdale, Nisha Bansal, Nicole S. Nevadunsky, Nicole Vilardo
Publikováno v:
Gynecologic Oncology. 162:S123-S124
Objectives: There is a paucity of data to determine the optimal adjuvant treatment of early-stage, high-risk endometrial histologies. While many retrospective series focus on uterine serous cancer, the optimal treament for other high risk subtypes, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccfd23b9dac973e9b2f2b24abf27408f
https://doi.org/10.1016/s0090-8258(21)00877-5
https://doi.org/10.1016/s0090-8258(21)00877-5
Autor:
Tiffany Hebert, Alexander Fife, Olivia Khouri, Mica Grantham, Joseph DiVito, Dennis Yi-Shin Kuo
Publikováno v:
Gynecologic Oncology Reports
Gynecologic Oncology Reports, Vol 34, Iss, Pp 100665-(2020)
Gynecologic Oncology Reports, Vol 34, Iss, Pp 100665-(2020)
Highlights • BioGlue™, a glutaraldehyde-based vessel sealant, can cause a foreign body reaction. • Vessel sealants may be used for IVC repair during endometrial cancer staging. • Foreign body reaction to BioGlue™ may look like a cancer recu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42c4a842124da512efad5d65b1295e03
https://doi.org/10.1016/j.gore.2020.100665
https://doi.org/10.1016/j.gore.2020.100665